Albert David Limited Stock NSE India S.E.

ALBERTDAVD

INE155C01010

Pharmaceuticals

Delayed NSE India S.E. 10:58:28 06/10/2026 +03			5-day change	1st Jan Change
831.00 ^INR	-0.65%		-5.17%	+12.82%

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Valuation: Albert David Limited

Market Cap	4.77B 49.5M 44.16M 41.14M 37.44M 70.51M 71.03M 497M 193M 2.43B 186M 182M 7.82B	P/E 2025	26.9x	P/E 2026	-224x
Enterprise Value	2.49B 25.83M 23.04M 21.47M 19.54M 36.79M 37.06M 259M 101M 1.27B 96.96M 94.87M 4.08B	EV / Sales 2025	0.67x	EV / Sales 2026	0.32x
Free-Float	35.96%	Yield 2025	0.62%	Yield 2026	0.85%

* Estimated data More valuation ratios

Latest news: Albert David Limited

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI
08-06	Albert David Limited Announces Resignation of Kuntal Ganguly from Head- R&D, Effective August 5, 2026	CI
05-30	Albert David Limited Announces Resignation of Chandra Bhushan Thakur from Head-Operations, Effective May 29, 2026	CI
05-12	Albert David appoints Amit Mahla as CEO effective May 12	RE
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Chief Executive Officer with Effect from May 12, 2026	CI
05-12	Albert David Limited Announces Appointment of Amit Mahla as the Key Managerial Personnel with Effect from May 12, 2026	CI
05-12	Albert David Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-12	Albert David Limited announces Annual dividend, payable on September 05, 2026	CI
02-11	Albert David Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
12-19	Albert David says Umesh Manohar Kunte resigns as MD, CEO	RE
12-18	Albert David says Umesh Manohar Kunte resigns as managing director and CEO	RE
12-18	Albert David Limited Announces Resignation of CEO Umesh Manohar Kunte, Effective December 18, 2025	CI

More news

Managers and Directors: Albert David Limited

Manager	Title	Age	Since
Amit Mahla CEO	Chief Executive Officer	52	12/05/2026
Ranadeep Bhattacharya DFI	Director of Finance/CFO	-	01/12/2020
Lalit Lohia CMP	Compliance Officer	-	-

Director	Title	Age	Since
Arun Kumar Kothari CHM	Chairman	73	30/12/2009
Prabhawati Devi Kothari BRD	Director/Board Member	69	31/03/2014
Monjori Mitra BRD	Director/Board Member	64	24/08/2020

More insiders

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Employees

1,476

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
06/10/26	₹831.00	-0.65%	1,611
05/10/26	₹836.45	-2.36%	2,685
01/10/26	₹856.70	-1.78%	11,319
30/09/26	₹872.25	-0.47%	6,427
29/09/26	₹876.35	+3.47%	13,163

Delayed Quote NSE India S.E.

More quotes

The best tools reserved for subscribers to boost the performance of your investments!

1 day	-0.65%
1 week	-5.17%
Current month	-4.73%
1 month	-3.71%
3 months	+17.31%
6 months	+26.08%
Current year	+12.82%

1 week	823.3	894.4
1 month	823.3	898
Current year	579.9	931.85
1 year	579.9	931.85
3 years	579.9	1,753.95
5 years	486.85	1,753.95
10 years	263	1,753.95

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALBERT DAVID LIMITED	-0.65%	-5.17%	-	-	49.5M
ELI LILLY AND COMPANY	+0.02%	-3.52%	+36.11%	+111.11%	1,019B
JOHNSON & JOHNSON	-1.21%	-6.99%	+34.08%	+60.96%	610B
ABBVIE INC.	+1.12%	-0.20%	+13.62%	+80.24%	470B
MERCK & CO., INC.	-3.30%	-6.15%	+56.45%	+34.69%	344B
ROCHE HOLDING AG	+1.28%	+1.43%	+22.85%	+42.81%	336B
NOVARTIS AG	+1.25%	-2.35%	+11.61%	+33.60%	266B
ASTRAZENECA PLC	+1.95%	-3.17%	-5.44%	+9.98%	241B
AMGEN INC.	-0.01%	-3.62%	+35.28%	+52.02%	218B
GILEAD SCIENCES, INC.	-0.08%	-4.98%	+28.34%	+93.61%	179B
Average	+0.56%	-3.63%	+25.88%	+57.67%	409.2B
Weighted average by Cap.	+0.75%	-3.51%	+28.68%	+68.93%

	2025	2026
Net sales	3.46B 35.9M 32.03M 29.84M 27.15M 51.14M 51.52M 361M 140M 1.76B 135M 132M 5.67B	3.34B 34.64M 30.9M 28.79M 26.2M 49.34M 49.7M 348M 135M 1.7B 130M 127M 5.47B
Net income	172M 1.79M 1.59M 1.48M 1.35M 2.54M 2.56M 17.94M 6.98M 87.79M 6.7M 6.56M 282M	-14.95M -155K -138K -129K -117K -221K -223K -1.56M -606K -7.63M -583K -570K -24.52M
Net Debt	-2.31B -24.02M -21.43M -19.96M -18.17M -34.21M -34.47M -241M -93.86M -1.18B -90.18M -88.23M -3.8B	-2.28B -23.67M -21.12M -19.68M -17.91M -33.72M -33.97M -238M -92.5M -1.16B -88.87M -86.96M -3.74B

Albert David Limited Stock NSE India S.E.

Stocks

ALBERTDAVD

INE155C01010

Pharmaceuticals

Valuation: Albert David Limited

Chart: Albert David Limited

Latest news: Albert David Limited

Quotes and Performance

Price Extremes

Managers and Directors: Albert David Limited

Generic Pharmaceuticals

Financials

Company Profile

Quotes